Back to top
more

Cross Country Healthcare (CCRN)

(Delayed Data from NSDQ)

$13.77 USD

13.77
665,898

+0.18 (1.32%)

Updated Sep 9, 2024 04:00 PM ET

After-Market: $13.76 -0.01 (-0.07%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

4-Sell of 5       4  

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value A Growth B Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 16% (210 out of 249)

Industry: Staffing Firms

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Verisk (VRSK) Riding on Growth Strategies, Debt Woes Stay

by Zacks Equity Research

Verisk (VRSK) remains focused on organic growth, product development and acquisitions.

Broadridge (BR) Rides on Recurring Revenues, Debt Woes Persist

by Zacks Equity Research

Broadridge (BR) has a robust business model that ensures significant recurring-fee revenues. A debt-laden balance sheet is concerning.

Automatic Data Processing (ADP) Rides on Buyouts, Debt Ails

by Zacks Equity Research

Automatic Data Processing's (ADP) top-line benefits from the favorable impact of acquisitions.

Cross Country Healthcare and AnheuserBusch InBev have been highlighted as Zacks Bull and Bear of the Day

by Zacks Equity Research

Cross Country Healthcare and AnheuserBusch InBev are part of Zacks Bull and Bear of the Day article.

Brian Bolan headshot

Bull Of The Day: Cross Country Healthcare (CCRN)

by Brian Bolan

A low single digit forward PE and outstanding growth too? Yes please, more of that!

FactSet (FDS) Stock Up 13.8% in a Year: What's Behind It?

by Zacks Equity Research

Consecutive better-than-expected top and bottom-line performance, shareholder-friendly moves and encouraging guidance have been benefiting the FactSet (FDS) stock.

IQVIA (IQV) Strong on IT Infrastructure Despite Debt Woes

by Zacks Equity Research

IQVIA (IQV) rides on a solid healthcare-specific global IT infrastructure and analytics-driven clinical development skills. However, a weak balance sheet is worrisome.

ICF International (ICFI) Banks on Prudent Strategies as Costs Ail

by Zacks Equity Research

The recent acquisition of Creative Systems and Consulting expands ICF International's (ICF) federal IT modernization/digital transformation capabilities.

H&R Block (HRB) Banks on Five-Year Strategy Amid Cost Pressures

by Zacks Equity Research

The main drivers of H&R Block's (HRB) post-pandemic performance can be digital enablement of its business, client addition and retention in Assisted and DIY, and greater usage of AI.

Zacks Value Trader Highlights: Bunge Limited, Titan International, Penske Automotive Group, Beazer Homes and Cross Country Healthcare

by Zacks Equity Research

Bunge Limited, Titan International, Penske Automotive Group, Beazer Homes and Cross Country Healthcare zacks Zacks Value Trader blog.

Tracey Ryniec headshot

Value Investors: Stick with the Basics in 2022

by Tracey Ryniec

A Zacks strong buy stock with a forward P/E of just 2.4? 5 great dirt-cheap stocks.

Zacks.com featured highlights include Atlas Air Worldwide, American Airlines, Cross Country Healthcare, Avnet, and Clearwater Paper

by Zacks Equity Research

Atlas Air Worldwide, American Airlines, Cross Country Healthcare, Avnet, and Clearwater Paper are part of Screen of the Week article.

Maharathi Basu headshot

Swear on 5 Broker-Friendly Stocks to Weather Market Storms

by Maharathi Basu

For remarkable returns, investors should keep broker-friendly stocks like Atlas Air Worldwide Holdings (AAWW), American Airlines (AAL), Cross Country Healthcare (CCRN), Avnet (AVT), and Clearwater Paper (CLW) on their radar.

Ritujay Ghosh headshot

4 Staffing Stocks to Buy on Steady Job Additions in U.S.

by Ritujay Ghosh

The United States has been adding a record number of jobs, helping staffing stocks like Kforce Inc. (KFRC), Resources Connection (RGP), KornFerry International (KFY) and Cross Country Healthcare (CCRN).

Paychex (PAYX) Stock Up 23.6% in a Year: What's Behind It?

by Zacks Equity Research

Consecutive better-than-expected top and bottom-line performance, shareholder-friendly moves and encouraging guidance have been benefiting the Paychex (PAYX) stock.

Cross Country Healthcare (CCRN) Q1 Earnings and Revenues Surpass Estimates

by Zacks Equity Research

Cross Country (CCRN) delivered earnings and revenue surprises of 21.43% and 6.07%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

Aptiv (APTV) to Report Q1 Earnings: What's in the Offing?

by Zacks Equity Research

Aptiv's (APTV) first-quarter 2022 revenues are likely to have increased year over year.

What's in Store for Republic Services (RSG) in Q1 Earnings?

by Zacks Equity Research

Republic Services' (RSG) first-quarter 2022 earnings and revenues are likely to have increased year over year.

Is a Beat in the Cards for FLEETCOR (FLT) in Q1 Earnings?

by Zacks Equity Research

FLEETCOR's (FLT) first-quarter 2022 earnings and revenues are expected to have improved year over year.

Is a Beat Ahead for Opendoor Technologies' (OPEN) Q1 Earnings?

by Zacks Equity Research

Opendoor Technologies' (OPEN) first-quarter 2022 revenues are expected to have benefited from an increase in home purchases.

Kforce (KFRC) Q1 Earnings and Revenues Beat Estimates

by Zacks Equity Research

Kforce (KFRC) delivered earnings and revenue surprises of 22.37% and 2.19%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

What's in Store for Trane Technologies (TT) in Q1 Earnings?

by Zacks Equity Research

Trane Technologies' (TT) first-quarter 2022 revenues are likely to have increased year over year.

Will Cross Country Healthcare (CCRN) Beat on Earnings in Q1?

by Zacks Equity Research

Cross Country Healthcare's (CCRN) first-quarter 2022 earnings and revenues are expected to have increased year over year.

What's in the Cards for Marathon Digital (MARA) in Q1 Earnings?

by Zacks Equity Research

Marathon Digital's first-quarter 2022 earnings and revenues are expected to have increased year over year.

Blucora (BCOR) to Report Q1 Earnings: What's in the Cards?

by Zacks Equity Research

Blucora's (BCOR) first-quarter 2022 earnings and revenues are likely to have improved year over year.